Top Markets
#1 Official Trump Official Trump +37.23%
#2 Siacoin Siacoin +22.82%
#3 Melania Meme Melania Meme +20.04%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +19.89%
#5 Pump.fun Pump.fun +19.64%
#6 Unit Pump Unit Pump +19.64%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +18.56%
#9 Wrapped POL Wrapped POL +17.44%
#10 Mubarak Mubarak +17.31%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Stella Pharma Corporation Stella Pharma Corporation

Stella Pharma Corporation

4888
Rank in Stocks #22897
Stella Pharma Corporation is a pharmaceutical company that handles the complete... Stella Pharma Corporation is a pharmaceutical company that handles the complete process of drug development, from research and manufacturing to distribution. A core area of its specialization is in therapeutic agents for boron neutron capture therapy (BNCT). Their product lineup includes SPM-011, a boron-containing drug designed for BNCT, which is utilized in the treatment of head and neck cancer, recurrent malignant glioma, meningioma, malignant melanoma, and angiosarcoma. Founded in 2007, Stella Pharma Corporation maintains its headquarters in Osaka, Japan.
Share Price
$2.26
Last synced: 2026-08-21
Market Cap
$81.55M
Change (1 day)
-0.86%
Change (1 year)
-18.45%
Country
JP
Trade Stella Pharma Corporation (4888)

Category

Healthcare
Revenue for Stella Pharma Corporation (4888)
Revenue in Aug 2026 TTM: 0
According to Stella Pharma Corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Stella Pharma Corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH